181782-18-3

Upstream product

• 169736-18-9 (2S,3R,4S)-3,4-bis(benzyloxy)-2-[(benzyloxy)methyl]-5-methoxyoxolane 
• 164200-61-7 (1S,2R,3R,4S)-2,3,5-Tris-benzyloxy-1-(1-trityl-1H-imidazol-2-yl)-pentane-1,4-diol 
• 16838-89-4 2,3,5-tri-O-benzyl-L-xylofuranose 
• 100-39-0 benzyl bromide 
• 13039-67-3 (2S,3S,4S)-2-(hydroxymethyl)-5-methoxyoxolane-3,4-diol 

Downstream Products

• 162491-59-0 (5R,6R,7R,8S)-6,7-bis(benzyloxy)-5-[(benzyloxy)methyl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridin-8-ol 
• 162491-58-9 (5R,6R,7R,8S)-8-azido-6,7-bis(benzyloxy)-5-[(benzyloxy)methyl]-5,6,7,8-tetrahydroimidazo[1,2-a]pyridine 

Relevant academic research and scientific papers

Total Syntheses of De-branched Nagstatin and Its Analogs Having Glycosidase Inhibiting Activities

De-branched nagstatin and its analogs have been synthesized from protected L-ribo- and xylo-furanoses through the inter- and intra-molecular nucleophilic reactions with the imidazole moieties.